A Phase I/II Study to Evaluate the Safety and Immunogenicity of ALVAC HIV Vaccines Alone and With AIDSVAX B/B in Children Born to HIV-Infected Mothers
Phase of Trial: Phase I/II
Latest Information Update: 17 May 2012
At a glance
- Drugs HIV gp120 vaccine (Primary) ; HIV vaccine vCP1452 (Primary)
- Indications HIV infections; HIV-1 infections
- Focus Adverse reactions; Pharmacodynamics
- 17 May 2012 Actual end date (Apr 2005) added as reported by ClinicalTrials.gov.
- 17 May 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Dec 2005 New trial record.